Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism

Luke Norton, M. Fourcaudot, Muhammad A Abdul-ghani, D. Winnier, F. F. Mehta, C. P. Jenkinson, Ralph A Defronzo

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Aims/hypothesis: The mechanisms by which transcription factor 7-like 2 (TCF7L2) regulates the pathways that are important in the pathogenesis of type 2 diabetes are unknown. We therefore examined the role of TCF7L2 in hepatic glucose production (HGP) in vitro and characterised the whole-genome chromatin occupancy of TCF7L2 in hepatocytes. Methods: We investigated the effect of TCF7L2 silencing and overexpression on HGP from gluconeogenic precursors and used chromatin-immunoprecipitation (ChIP) combined with massively parallel DNA sequencing (ChIP-Seq) to investigate the DNA binding patterns of TCF7L2 across the whole genome. Results: Silencing of TCF7L2 induced a marked increase in basal HGP, which was accompanied by significant increases in the expression of the gluconeogenic genes Fbp1, Pck1 and G6pc. Overexpression of Tcf7l2 reversed this phenotype and significantly reduced HGP. TCF7L2 silencing did not affect the half-maximal inhibitory concentration of insulin or metformin, but HGP remained elevated in TCF7L2-silenced cells due to the increased baseline HGP. Using ChIP-Seq, we detected 2,119 binding events across the genome. Pathway analysis demonstrated that diabetes genes were significantly over-represented in the dataset. Our results indicate that TCF7L2 binds directly to multiple genes that are important in regulation of glucose metabolism in the liver, including Pck1, Fbp1, Irs1, Irs2, Akt2, Adipor1, Pdk4 and Cpt1a. Conclusions/ interpretation: TCF7L2 is an important regulator of HGP in vitro and binds directly to genes that are important in pathways of glucose metabolism in the liver. These data highlight the possibility that TCF7L2 may affect fasting and postprandial hyperglycaemia in carriers of at-risk TCF7L2 genetic polymorphisms.

Original languageEnglish (US)
Pages (from-to)3132-3142
Number of pages11
JournalDiabetologia
Volume54
Issue number12
DOIs
StatePublished - Dec 2011

Fingerprint

T Cell Transcription Factor 1
Chromatin
Glucose
Liver
Chromatin Immunoprecipitation
Genome
Genes
High-Throughput Nucleotide Sequencing
Metformin
Genetic Polymorphisms
DNA Sequence Analysis

Keywords

  • Hepatic glucose metabolism
  • TCF7L2
  • Type 2 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Norton, L., Fourcaudot, M., Abdul-ghani, M. A., Winnier, D., Mehta, F. F., Jenkinson, C. P., & Defronzo, R. A. (2011). Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism. Diabetologia, 54(12), 3132-3142. https://doi.org/10.1007/s00125-011-2289-z

Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism. / Norton, Luke; Fourcaudot, M.; Abdul-ghani, Muhammad A; Winnier, D.; Mehta, F. F.; Jenkinson, C. P.; Defronzo, Ralph A.

In: Diabetologia, Vol. 54, No. 12, 12.2011, p. 3132-3142.

Research output: Contribution to journalArticle

Norton, L, Fourcaudot, M, Abdul-ghani, MA, Winnier, D, Mehta, FF, Jenkinson, CP & Defronzo, RA 2011, 'Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism', Diabetologia, vol. 54, no. 12, pp. 3132-3142. https://doi.org/10.1007/s00125-011-2289-z
Norton L, Fourcaudot M, Abdul-ghani MA, Winnier D, Mehta FF, Jenkinson CP et al. Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism. Diabetologia. 2011 Dec;54(12):3132-3142. https://doi.org/10.1007/s00125-011-2289-z
Norton, Luke ; Fourcaudot, M. ; Abdul-ghani, Muhammad A ; Winnier, D. ; Mehta, F. F. ; Jenkinson, C. P. ; Defronzo, Ralph A. / Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism. In: Diabetologia. 2011 ; Vol. 54, No. 12. pp. 3132-3142.
@article{203caad33bb14fae83f4c87b97096a5d,
title = "Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism",
abstract = "Aims/hypothesis: The mechanisms by which transcription factor 7-like 2 (TCF7L2) regulates the pathways that are important in the pathogenesis of type 2 diabetes are unknown. We therefore examined the role of TCF7L2 in hepatic glucose production (HGP) in vitro and characterised the whole-genome chromatin occupancy of TCF7L2 in hepatocytes. Methods: We investigated the effect of TCF7L2 silencing and overexpression on HGP from gluconeogenic precursors and used chromatin-immunoprecipitation (ChIP) combined with massively parallel DNA sequencing (ChIP-Seq) to investigate the DNA binding patterns of TCF7L2 across the whole genome. Results: Silencing of TCF7L2 induced a marked increase in basal HGP, which was accompanied by significant increases in the expression of the gluconeogenic genes Fbp1, Pck1 and G6pc. Overexpression of Tcf7l2 reversed this phenotype and significantly reduced HGP. TCF7L2 silencing did not affect the half-maximal inhibitory concentration of insulin or metformin, but HGP remained elevated in TCF7L2-silenced cells due to the increased baseline HGP. Using ChIP-Seq, we detected 2,119 binding events across the genome. Pathway analysis demonstrated that diabetes genes were significantly over-represented in the dataset. Our results indicate that TCF7L2 binds directly to multiple genes that are important in regulation of glucose metabolism in the liver, including Pck1, Fbp1, Irs1, Irs2, Akt2, Adipor1, Pdk4 and Cpt1a. Conclusions/ interpretation: TCF7L2 is an important regulator of HGP in vitro and binds directly to genes that are important in pathways of glucose metabolism in the liver. These data highlight the possibility that TCF7L2 may affect fasting and postprandial hyperglycaemia in carriers of at-risk TCF7L2 genetic polymorphisms.",
keywords = "Hepatic glucose metabolism, TCF7L2, Type 2 diabetes",
author = "Luke Norton and M. Fourcaudot and Abdul-ghani, {Muhammad A} and D. Winnier and Mehta, {F. F.} and Jenkinson, {C. P.} and Defronzo, {Ralph A}",
year = "2011",
month = "12",
doi = "10.1007/s00125-011-2289-z",
language = "English (US)",
volume = "54",
pages = "3132--3142",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "12",

}

TY - JOUR

T1 - Chromatin occupancy of transcription factor 7-like 2 (TCF7L2) and its role in hepatic glucose metabolism

AU - Norton, Luke

AU - Fourcaudot, M.

AU - Abdul-ghani, Muhammad A

AU - Winnier, D.

AU - Mehta, F. F.

AU - Jenkinson, C. P.

AU - Defronzo, Ralph A

PY - 2011/12

Y1 - 2011/12

N2 - Aims/hypothesis: The mechanisms by which transcription factor 7-like 2 (TCF7L2) regulates the pathways that are important in the pathogenesis of type 2 diabetes are unknown. We therefore examined the role of TCF7L2 in hepatic glucose production (HGP) in vitro and characterised the whole-genome chromatin occupancy of TCF7L2 in hepatocytes. Methods: We investigated the effect of TCF7L2 silencing and overexpression on HGP from gluconeogenic precursors and used chromatin-immunoprecipitation (ChIP) combined with massively parallel DNA sequencing (ChIP-Seq) to investigate the DNA binding patterns of TCF7L2 across the whole genome. Results: Silencing of TCF7L2 induced a marked increase in basal HGP, which was accompanied by significant increases in the expression of the gluconeogenic genes Fbp1, Pck1 and G6pc. Overexpression of Tcf7l2 reversed this phenotype and significantly reduced HGP. TCF7L2 silencing did not affect the half-maximal inhibitory concentration of insulin or metformin, but HGP remained elevated in TCF7L2-silenced cells due to the increased baseline HGP. Using ChIP-Seq, we detected 2,119 binding events across the genome. Pathway analysis demonstrated that diabetes genes were significantly over-represented in the dataset. Our results indicate that TCF7L2 binds directly to multiple genes that are important in regulation of glucose metabolism in the liver, including Pck1, Fbp1, Irs1, Irs2, Akt2, Adipor1, Pdk4 and Cpt1a. Conclusions/ interpretation: TCF7L2 is an important regulator of HGP in vitro and binds directly to genes that are important in pathways of glucose metabolism in the liver. These data highlight the possibility that TCF7L2 may affect fasting and postprandial hyperglycaemia in carriers of at-risk TCF7L2 genetic polymorphisms.

AB - Aims/hypothesis: The mechanisms by which transcription factor 7-like 2 (TCF7L2) regulates the pathways that are important in the pathogenesis of type 2 diabetes are unknown. We therefore examined the role of TCF7L2 in hepatic glucose production (HGP) in vitro and characterised the whole-genome chromatin occupancy of TCF7L2 in hepatocytes. Methods: We investigated the effect of TCF7L2 silencing and overexpression on HGP from gluconeogenic precursors and used chromatin-immunoprecipitation (ChIP) combined with massively parallel DNA sequencing (ChIP-Seq) to investigate the DNA binding patterns of TCF7L2 across the whole genome. Results: Silencing of TCF7L2 induced a marked increase in basal HGP, which was accompanied by significant increases in the expression of the gluconeogenic genes Fbp1, Pck1 and G6pc. Overexpression of Tcf7l2 reversed this phenotype and significantly reduced HGP. TCF7L2 silencing did not affect the half-maximal inhibitory concentration of insulin or metformin, but HGP remained elevated in TCF7L2-silenced cells due to the increased baseline HGP. Using ChIP-Seq, we detected 2,119 binding events across the genome. Pathway analysis demonstrated that diabetes genes were significantly over-represented in the dataset. Our results indicate that TCF7L2 binds directly to multiple genes that are important in regulation of glucose metabolism in the liver, including Pck1, Fbp1, Irs1, Irs2, Akt2, Adipor1, Pdk4 and Cpt1a. Conclusions/ interpretation: TCF7L2 is an important regulator of HGP in vitro and binds directly to genes that are important in pathways of glucose metabolism in the liver. These data highlight the possibility that TCF7L2 may affect fasting and postprandial hyperglycaemia in carriers of at-risk TCF7L2 genetic polymorphisms.

KW - Hepatic glucose metabolism

KW - TCF7L2

KW - Type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=82455212297&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82455212297&partnerID=8YFLogxK

U2 - 10.1007/s00125-011-2289-z

DO - 10.1007/s00125-011-2289-z

M3 - Article

VL - 54

SP - 3132

EP - 3142

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 12

ER -